Try our beta test site

Panobinostat (LBH589) in Patients With Metastatic Melanoma

This study has been completed.
Brigham and Women's Hospital
Information provided by (Responsible Party):
F. Stephen Hodi, MD, Dana-Farber Cancer Institute Identifier:
First received: February 8, 2010
Last updated: March 27, 2017
Last verified: March 2017
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 13, 2017
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)